EcoDrugPlus

Ensembl ID : ENSCCRG00000011139
Gene Symbol: -
Cross references: -
244 Possible Orthologues:

Ensembl ID : ENSCCRG00000011048
Gene Symbol: PSMD11A
1 Cross references
150 Possible Orthologues:

Ensembl ID : ENSCCRG00000010676
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSCCRG00000081672
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSCCRG00000081714
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSCCRG00000010523
Gene Symbol: RPL35
1 Cross references
256 Possible Orthologues:

Ensembl ID : ENSCCRG00000081846
Gene Symbol: -
Cross references: -
169 Possible Orthologues:

Ensembl ID : ENSCCRG00000010466
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSCCRG00000082243
Gene Symbol: RPL34
1 Cross references
361 Possible Orthologues:

Ensembl ID : ENSCCRG00000010248
Gene Symbol: -
Cross references: -
150 Possible Orthologues:

Ensembl ID : ENSCCRG00000008176
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSCCRG00000004869
Gene Symbol: -
Cross references: -
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).